Re: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

European Urology

Volumn 64, Issue 6, 2013, Pages 1015-1016

  Chow, Ken ^a   Murphy, Declan G ^a,b,c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c Victoria Orthopaedic Foot and Ankle Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; SELENIUM; OMEGA 6 FATTY ACID;

BLOOD CHEMISTRY; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; DIET SUPPLEMENTATION; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; HAZARD RATIO; HUMAN; LOW FAT DIET; NOTE; OBSERVATIONAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; BLOOD; MALE; PROSTATE TUMOR;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84887369093     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.09.032     Document Type: Note

References (0)